2016 Hematological Malignancies

865 / 1835

What is new?
(compared to 2007)
Staging:
 PET/CT for routine staging of FDG-avid Lymphomas
 BMBx not required for HL and most DLBCL
 Simplification of Ann Arbor
Response assessment:
 PET/CT is standard of care for remission assessment
 Standard tool for reporting response is 5-PS (Deauville criteria)
 Deauville Criteria can be used to assign metabolic response categories (CMR, PMR, NMR, PMD)
 Revised CT size criteria
Surveillance:
 Routine scanning discouraged.